Develops abuse deterrent abuse resistant formulations in analgesics
Palatine, IL
NASDAQ: ACUR
Contact: Immanuel Thangaraj
Formerly Known As: Halsey Drug Company
Rapidly growing Latin American specialty pharma company
Bogota, Colombia
Contact: Toby Sykes
Related News
Lured by Rising Healthcare Demand, Essex Woodlands Enters Latin America
Develops drug delivery products and devices using proprietary Corplex hydrogel technology
Menlo Park, CA
Contact: Ron Eastman
Formerly Known As: Stratagent Life Sciences
Related News
Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors
Develops topical formulations for pharmaceutical and biotech companies
Petaluma, CA
NYSE: VRX
Contact: Jim Currie
Acquisition
Acquired by: Valeant Pharmaceuticals International
Exit date: December 10, 2008
![]()
Related News
Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million
Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care
Oxford, United Kingdom
Contact: Petri Vainio
Related News
Essex Woodlands’ Bet on Bryan Morton Pays Off, as EUSA Sells to Jazz Pharma
Focuses on acquiring, developing and investing in products to translate innovative science into meaningful health care consumer brands
Nottingham, United Kingdom
Other OTC: MEDAa.ST
Contact: Petri Vainio
www.healthcarebrandsinternational.com
Acquisition
Acquired by: Meda AB
Exit date: April 21, 2011
![]()
Related News
Focuses on rapid development of prescription drugs for mild to moderate pain relief
Northbrook, IL
Contact: Jeff Himawan
Formerly Known As: Horizon Therapeutics
Related News
Focuses on acquiring and developing novel, small-molecule therapeutics for the US market
San Diego, CA
NASDAQ: MNOV
Contact: Jeff Himawan
Related News
MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd.
Develops peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems
Cranbury, NJ
NYSE: PTN
Contact: Richard Kolodziejcyk
Develops products which improve and restore blood flow
Lexington, MA
Contact: Cynthia Doerr
Formerly Known As: eNOS Pharmaceuticals
Assists clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products for safe and effective treatments
Boston, MA
NASDAQ: NasdaqGS: PRXL
Contact: Jim Currie
Formerly Known As: Parexel
IPO
Acquired by: Parexel International
Exit date: November 30, 1995
Develops, manufactures, acquires and markets dermatology products
Cumberland, Rhode Island
Contact: Immanuel Thangaraj
Related News
PreCision Dermatology Forms with Onset Therapeutics as Core Commercial and Technology Base
Develops and commercializes branded cardiovascular injectable products
King of Prussia, PA
NYSE: BAX
Contact: Jim Currie
Formerly Known As: Prism Pharmaceuticals
Acquisition
Acquired by: Baxter International
Exit date: April 18, 2011
![]()
Related News
Baxter Announces the Acquisition of Prism
Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue
Newark, CA
Contact: Ron Eastman
Formerly Known As: Essentia BioSystems Inc.
Related News
Revance Announces $45M Financing
Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases
Palo Alto, CA
Contact: Ron Eastman
Acquisition
Acquired by: Pfizer, Inc.
Exit date: April 06, 2006

Related News
Pfizer to Buy Rinat, a Biotechnology Drug Maker
Provides biological products and enabling technologies to life sciences companies for use in the research, development, and manufacture of new drugs and other life sciences products
Pensacola, FL
Contact: Jim Currie
Acquisition
Acquired by: Millipore
Exit date: July 14, 2006
Focuses on enabling people with life-altering conditions to lead better lives
Wayne, PA
NASDAQ: SHPGY
Contact: Jim Currie
Acquisition
Acquired by: Richwood Pharmaceuticals
Exit date: August 06, 1997
Develops pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products
Yardley, PA
Contact: Scott Barry
Related News
FidoPharm and the ASPCA Team Up to Launch New PetArmor Over-the-Counter Flea and Tick Treatment
Acquires, develops and markets prescription pharmaceutical products to treat pain and related conditions
San Diego, CA
Contact: Scott Barry
Acquisition
Acquired by: Shionogi
Exit date: July 18, 2011
![]()
Related News
Develops prescription pharmaceuticals in women's health
Newport, KY
Contact: Jim Currie
Formerly Known As: Integrity Pharmaceuticals
Related News
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies
Focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders (formerly known as Zonagen)
The Woodlands, TX
NASDAQ: RPRX
Contact: Marty Sutter



